| Central Park Counseling | |
|
2011 Dallas St Aurora CO 80010-0000 | |
| (720) 224-2574 | |
| Not Available |
| Full Name | Central Park Counseling |
|---|---|
| Speciality | Counselor - Professional |
| Location | 2011 Dallas St, Aurora, Colorado |
| Authorized Official Name and Position | Amber D Mccallum Foote (AUTHORIZED MANAGER/ USER) |
| Authorized Official Contact | 7207297372 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Central Park Counseling 6909 S Holly Cir Ste 304 Centennial CO 80112-1045 Ph: (720) 224-2574 | Central Park Counseling 2011 Dallas St Aurora CO 80010-0000 Ph: (720) 224-2574 |
| NPI Number | 1144994633 |
|---|---|
| Provider Enumeration Date | 08/06/2021 |
| Last Update Date | 10/26/2023 |
| Certification Date | 10/26/2023 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144994633 | NPI | - | NPPES |
News Archive
What if a single smartphone app could help solve the enigma of multiple sclerosis and move new treatments ahead at lightning speed? That was the bold idea that led Keck Medicine of USC neurologist Daniel Pelletier, MD, professor of neurology at the Keck School of Medicine of USC and division chief of the Neuro-Immunology and USC Multiple Sclerosis Center, to develop myMS, the world's first smartphone app capable of collecting large amounts of clinical, imaging and genetic data for people with MS. Enrollment is now underway for a pilot study of the app.
Indivior PLC today announced top-line results from its phase 3 clinical trial of RBP-7000, an investigational drug in development for the treatment of schizophrenia. In this pivotal study, both doses of RBP-7000 tested, 90 mg and 120 mg administered once-monthly, met the primary endpoint with statistically and clinically significant reductions in the symptoms of acute schizophrenia over an 8-week treatment period.
Infinity Pharmaceuticals, Inc. announced that results from its Phase 2 study of IPI-504, a novel IV-administered Hsp90 chaperone inhibitor, in patients with advanced non-small cell lung cancer (NSCLC) were published in the Journal of Clinical Oncology.
Boehringer Ingelheim is pleased to announce the last patients have been randomised into the Phase III sister trials assessing the efficacy and safety of nintedanib (150 mg twice daily) in patients with idiopathic pulmonary fibrosis (IPF).
› Verified 6 days ago
Aurora Mental Health Center Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 10782 E Alameda Ave, Aurora, CO 80012 Phone: 303-617-2300 | |
Aurora Arapahoe Battered Women's Shelter Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1181 Dallas St, Aurora, CO 80010 Phone: 303-343-1856 | |
Willow Grove Mental Health, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 14211 E 4th Ave, Aurora, CO 80011 Phone: 720-262-9100 Fax: 720-262-9101 | |
Spanish Clinic Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1400 Dayton St, Aurora, CO 80010 Phone: 303-934-3040 | |
Action Behavior Centers, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 18737 E Hampden Ave, Aurora, CO 80013 Phone: 720-588-1500 | |
Aurora Comprehensive Community Mental Health Center Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 16905 E 2nd Ave, Aurora, CO 80011 Phone: 303-617-2300 | |
Amy Shandy, Speech-language Pathologist, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3131 S Vaughn Way Ste 110, Aurora, CO 80014 Phone: 719-597-0822 Fax: 719-599-4606 |